1) Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 104:1258-1265, 2004
2) Hainsworth JD, Litchy S, Burris HA 3rd, et al. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma. J Clin Oncol 20:4261-4267, 2002
3) Witzig TE, Vukov AM, Habermann TM, et al. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma:a phase II trial in the North Central Cancer Treatment Group. J Clin Oncol 23:1103-1108, 2005
4) Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma:long-term follow-up of no initial therapy. J Clin Oncol 22:1454-1459, 2004
5) Hiddemann W, Buske C, Dreyling M, et al. Treatment strategies in follicular lymphomas:current status and future perspectives. J Clin Oncol 23:6394-6399, 2005
6) Damaj G, Verkarre V, Delmer A, et al. Primary follicular lymphoma of the gastrointestinal tract:a study of 25 cases and a literature review. Ann Oncol 14:623-629, 2003